Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bio Cybernetics International was a medical device company specializing in innovative orthopedic and trauma care solutions. The company was widely recognized for its "Mechanical Advantage" technology, which utilized a unique pulley system to provide superior compression and stabilization in spinal and pelvic orthoses. Its flagship products included the T-POD for pelvic trauma stabilization and the Mechanical Advantage Tourniquet (MAT) for rapid hemorrhage control. In 2008, the company's trauma assets were acquired by Pyng Medical, while its orthopedic bracing line continued under the Cybertech Medical brand. The company's legacy lives on through its specialized emergency medicine and rehabilitation products now integrated into larger medical technology portfolios.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bio Cybernetics International.